2004 marked the beginning of Distribo, a joint venture between Sartorius Stedim Biotech and Friedrich Zufall GmbH & Co. KG, when Sartorius' warehousing and logistics operations were spun off. The joint venture Distribo was created.
In 2014 Distribo opened its new logistics center at the Siekanger site in Goettingen, Germany, with an area of around 15,000 m². From here, both the worldwide shipment of laboratory and process technology products and the production supply of all Sartorius locations in Goettingen are carried out.
In 2016, the warehouse space was expanded from 15,000 to 25,000 square meters. The growth of Sartorius requires an expansion of the logistics area in Goettingen. For this purpose, ZUFALL logistics group is investing around five million euros in the expansion.
The history of Sartorius began more than a century ago. In 1890, Carl Sartorius founded the company in Goettingen, Germany. Originally, it specialized in the manufacture of precision balances for scientific purposes.
Over time, the company expanded its product portfolio and focused on the areas of biotechnology and life sciences. In the 1960er, Sartorius developed innovative solutions for filtration technology that were of great importance for biopharmaceuticals.
In the 1980s, Sartorius entered into a strategic partnership with the French company Stedim. This collaboration led to the creation of Sartorius Stedim Biotech in 1987, combining the strengths and expertise of both partners to become a global leader in bioprocess technology.
Sartorius Stedim Biotech developed advanced solutions for biopharmaceuticals and contributed significantly to the development of new drugs and therapies. The company continuously invested in research and development to create innovative technologies and products to meet the needs of the ever-evolving biotech industry.
In 2007, Sartorius Stedim Biotech opened a state-of-the-art biotech center in Goettingen, Germany, which became an important hub for research and development as well as production. The company continued to expand globally, establishing subsidiaries and production facilities in various countries to meet the needs of its international customers.
In 2020, Sartorius Stedim Biotech played a crucial role in the development and production of COVID-19 vaccines. The company supported numerous pharmaceutical companies in scaling up their vaccine production and thus contributed to the fight against the pandemic.
Today, Sartorius Stedim Biotech is a global leader in bioprocess technology. It offers innovative solutions for the biopharmaceutical industry, including filtration systems, fermentation technologies, cell culture media and analytical instruments. The company remains committed to research, innovation and sustainability to drive the future of biotechnology and improve the health and well-being of people worldwide.
The story of Friedrich Zufall begins in 1928, when he founded Hessische Fern-Verkehr Friedrich Zufall GmbH in Kassel. The company started as a regional freight forwarder and focused on long-distance transport.
In the following years, the company grew steadily and opened branches in various cities. 1934-1937 branches were added in Fulda and Göttingen as well as Bremen and Bremerhaven. Friedrich Zufall led the company with great entrepreneurial spirit and a vision for growth and success.
During the Second World War, Kassel was bombed repeatedly, and so Friedrich Zufall decided in 1942/43 to move the company's headquarters to Göttingen in order to continue its business activities. After the death of Friedrich Zufall in the same year, Gerhard F. Müller took over the management and acquired the company shares in Osterode, Hann. Münden and Hamburg.
In 1948 the company was renamed Hessisch-Südhannoverscher Fernverkehr Friedrich Zufall, and in 1965 it was finally renamed Friedrich Zufall Internationale Spedition (since 1976 GmbH & Co. KG).
The Friedrich Zufall company continued to expand and joined Transland Spedition GmbH and Team Trans Hamburg GmbH in 2007 and Team Trans Logistics GmbH (2016). Through these strategic partnerships, the company strengthened its range of services in the areas of land transport and sea freight.
In 2013, Peter Müller-Kronberg, Gerhard Müller's son, joined Jürgen Wolpert in the management of the family business. They continued the legacy of Friedrich Zufall and further expanded the company.
Today Friedrich Zufall is a respected international freight forwarder with a wide range of services. The company offers customized logistics solutions for customers from various industries and is known for its reliability and efficiency. Under the leadership of Peter Müller-Kronberg and Jürgen Wolpert, Friedrich Zufall remains a major player in the transport and logistics industry and is committed to first-class service and customer satisfaction.